HCC in the Setting of Hepatitis B: Asia-Pacific Considerations

In these slides, expert faculty discusses Asia-Pacific considerations relevant to patients with HCC in the setting of hepatitis B.
Grace LH Wong, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 691 KB
Released: June 10, 2021

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@clinicaloptions.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by:
Gilead Sciences, Inc.

Related Content

Clinical Care Options (CCO) expert commentary on optimal timing for MTCT prophylaxis in pregnant women with chronic HBV

Joseph Ahn, MD, MS, MBA Released: July 13, 2021

Brief Clinical Care Options (CCO) presentation on AASLD guidance on treatment indications and treatment options for pregnant women with chronic HBV infection

Joseph Ahn, MD, MS, MBA Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: July 8, 2021 Expired: July 7, 2022

Download free slides reviewing key data and AASLD guidance on managing HBV infection during pregnancy

Joseph Ahn, MD, MS, MBA Released: July 8, 2021

Clinical Care Options (CCO) expert commentary from Francesco Negro, MD, on managing coinfection with hepatitis B and hepatitis D viruses

Francesco Negro, MD Released: July 7, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue